로딩 중…
지수 로딩 중…
Liquidia Corporation
LQDA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$71.07+3.53%
2026-06-18
Price Chart
Liquidia Corporation+421.04%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $6.32B |
| Revenue | $288M |
| Net Income | $22M |
| Total Assets | $402M |
| Net Assets | $109M |
| Value | |
| P/E | 283.35x |
| P/B | 58.21x |
| P/S | 21.94x |
| EV/EBITDA | 120.76x |
| FCF Yield | 0.65% |
| Profitability | |
| ROE | 20.54% |
| ROA | 5.55% |
| Op. Margin | 15.81% |
| Revenue Growth | 4158.49% |
| Financial Health | |
| Debt Ratio | 269.81% |
| Total Debt | $185M |
| FCF | $41M |
| Cash | $223M |
| Current Ratio | 2.22x |
| Net Debt/EBITDA | -0.73x |
| Performance | |
| 1Y Return | 421.04% |
| 1M Return | 18.49% |
| From 52W High | -2.94% |
| 1Y MDD | -37.82% |
| Trading | |
| Volume | 9,577,950 shares |
| Trading Value | $670M |
| Per Share | |
| EPS | $-0.79 |
| BPS | $0.51 |